Installer Kaleta App
Accès rapide & mode hors-ligne
Novartis, a leading global healthcare company, was established in 1996 through the merger of Ciba-Geigy and Sandoz, two Swiss companies with a rich heritage in pharmaceuticals and chemicals. Headquartered in Basel, Switzerland, Novartis operates in over 155 countries, including a significant presence across Africa. The company’s mission is to reimagine medicine by developing innovative products that address unmet medical needs and improve the quality of life for patients worldwide.
Novartis is renowned for its robust portfolio of medicines, including treatments for cancer, cardiovascular diseases, and neurological disorders. The company reaches millions of patients annually, with a commitment to expanding access to healthcare in underserved regions. Through initiatives like the Novartis Access program, it provides affordable treatments for chronic diseases in low-income countries, significantly contributing to global health improvements and socio-economic development.
Novartis has a significant footprint in Africa, with operations in countries such as South Africa, Kenya, Nigeria, and Egypt. These regional hubs serve as pivotal points for distributing medicines and implementing health initiatives across the continent, focusing on improving access to essential healthcare services.
The Novartis Access program is a flagship initiative that offers a portfolio of medicines to treat chronic diseases at a cost of one dollar per treatment per month in low-income countries. Additionally, Novartis partners with various organizations to enhance healthcare infrastructure and training in Africa.
Novartis has achieved significant milestones, such as reaching over 24 million patients through its access programs and investing in research and development to innovate new treatments. The company’s efforts in Africa have been recognized for improving healthcare outcomes and contributing to the fight against diseases like malaria and sickle cell anemia.
